Variceal Bleeding Clinical Trials

5 recruiting

Variceal Bleeding Trials at a Glance

8 actively recruiting trials for variceal bleeding are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Asyut, Beijing, and Changsha. Lead sponsors running variceal bleeding studies include C. R. Bard, Chinese University of Hong Kong, and Assiut University.

Browse variceal bleeding trials by phase

About Variceal Bleeding Clinical Trials

Looking for clinical trials for Variceal Bleeding? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Variceal Bleeding trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Variceal Bleeding clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients

Hepatocellular CarcinomaVariceal Bleeding
Chinese University of Hong Kong84 enrolled1 locationNCT05629845
Recruiting

Construction of a Portal Hypertension Biobank

Portal HypertensionVariceal Bleeding
Shanghai Zhongshan Hospital1,000 enrolled1 locationNCT07419724
Recruiting
Not Applicable

Underdilated-stent Technique Improves Post-TIPS Encephalopathy

Liver CirrhosisAscites HepaticVariceal Bleeding, Cirrhosis+1 more
The Second Affiliated Hospital of Chongqing Medical University72 enrolled2 locationsNCT07349654
Recruiting
Not Applicable

Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal Hypertension

Portal Hypertension Related to CirrhosisVariceal BleedingAscites Hepatic
C. R. Bard166 enrolled1 locationNCT06669806
Recruiting
Phase 4

Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients

CirrhosisUpper Gastrointestinal Bleeding (UGIB)Variceal Bleeding
Tanta University194 enrolled1 locationNCT06881628
Recruiting
Not Applicable

Removable Titanium Clip Treatment for Acute Variceal Hemorrhage from the Gastric Fundus

Gastric Variceal Bleeding
Shupei Li10 enrolled1 locationNCT06736314
Recruiting
Not Applicable

Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma

Advanced Hepatocellular CarcinomaVariceal Bleeding
Sun Yat-sen University22 enrolled2 locationsNCT06624098
Recruiting

Albumin Bilirubin Index as a Predictor of Outcome of Variceal Bleeding

Prediction of Variceal Bleeding
Assiut University48 enrolled1 locationNCT06614114